Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer

被引:86
|
作者
Slotman, BJ
Antonisse, IE
Njo, KH
机构
[1] Department of Radiation Oncology, Free University Hospital, 1081 HV, Amsterdam
关键词
non-small cell lung cancer; radiotherapy; curative radiotherapy; elective radiotherapy; postage stamp fields;
D O I
10.1016/S0167-8140(96)91827-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Radiotherapy can effectively control non-small cell lung cancers (NSCLC) of limited size. This study is conducted to investigate whether limited field irradiation, without irradiation of regional lymph nodes, can safely be used in these patients. Materials and methods: Between 1988 and 1993, 31 patients with operable T1-2N0 NSCLC received radiotherapy (48 Gy in 12 fractions) to a limited ('postage stamp') field. The hilum and mediastinum were not included in the radiation portals. Results: Overall survival was 42% at 3 years. Disease-specific survival at 3 years was 76%. One patient developed an isolated regional failure, one had a combined local and distant failure, one had a combined local, regional and distant failure, while three patients failed at distant sites only. Thus, only two patients (6%) recurred regionally. Conclusions: This study shows that 'postage stamp' irradiation is an effective alternative to sugery. Radiation of the hilar and mediastinal lymph nodes can be omitted in these pulmonary compromised patients.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 50 条
  • [1] Role of adjuvant therapy in T1-2N0 resected non-small cell lung cancer
    Woodard, Gavitt A.
    Li, Andrew
    Boffa, Daniel J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (05): : 1685 - 1692
  • [2] Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
    Speicher, Paul J.
    Gu, Lin
    Wang, Xiaofei
    Hartwig, Matthew G.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06): : 755 - 761
  • [3] Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer
    Xia, Qing
    Zhu, Zhihua
    Wang, Jian
    Situ, Dongrong
    Zhou, Ningning
    Jang, Wenqi
    TUMOR BIOLOGY, 2012, 33 (05) : 1719 - 1725
  • [4] Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer
    Hayakawa, K
    Mitsuhashi, N
    Saito, Y
    Nakayama, Y
    Furuta, M
    Sakurai, H
    Kawashima, M
    Ohno, T
    Nasu, S
    Niibe, H
    LUNG CANCER, 1999, 26 (03) : 137 - 142
  • [5] Stereotactic radiotherapy for early-stage (T1-2N0) small cell lung cancer: Where are we now and where are we going?
    Verma, Vivek
    LUNG CANCER, 2021, 160 : 187 - 189
  • [6] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Hiroaki Nomori
    Surgery Today, 2014, 44 : 812 - 819
  • [7] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Nomori, Hiroaki
    SURGERY TODAY, 2014, 44 (05) : 812 - 819
  • [8] Predictors and Outcomes of Limited Resection for Early-Stage Non-Small Cell Lung Cancer
    Billmeier, Sarah E.
    Ayanian, John Z.
    Zaslavsky, Alan M.
    Nerenz, David R.
    Jaklitsch, Michael T.
    Rogers, Selwyn O.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (21): : 1621 - 1629
  • [9] Limited resection versus lobectomy in early-stage non-small cell lung cancer
    Toste, Paul A.
    Lee, Jay M.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : E1511 - E1513
  • [10] T2N1M0 non-small cell lung cancer:: Surgery and prognostic factors
    Padilla, J
    Calvo, V
    Peñalver, JC
    Jordá, C
    Escrivá, J
    Cerón, J
    Zarza, AG
    Pastor, J
    Blasco, E
    ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (08): : 430 - 433